OpGen (LTS:0A8L) Change In Inventory : $0.16 Mil (TTM As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is OpGen Change In Inventory?

OpGen's change in inventory for the quarter that ended in Sep. 2023 was $0.30 Mil. It means OpGen's inventory declined by $0.30 Mil from Jun. 2023 to Sep. 2023 .

OpGen's change in inventory for the fiscal year that ended in Dec. 2022 was $-0.73 Mil. It means OpGen's inventory increased by $0.73 Mil from Dec. 2021 to Dec. 2022 .

OpGen's Total Inventories for the quarter that ended in Sep. 2023 was $1.20 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. OpGen's Days Inventory for the quarter that ended in Sep. 2023 was 193.38.

Inventory Turnover measures how fast the company turns over its inventory within a year. OpGen's Inventory Turnover for the quarter that ended in Sep. 2023 was 0.47.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. OpGen's Inventory-to-Revenue for the quarter that ended in Sep. 2023 was 2.10.

OpGen Change In Inventory Historical Data

The historical data trend for OpGen's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OpGen Change In Inventory Chart

OpGen Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Inventory

Get a 7-Day Free Trial

-0.01

0.07

-0.41

-2.34

-0.73

OpGen Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Change In Inventory	Get a 7-Day Free Trial															-0.31	-0.13	-0.20	0.19	0.30

OpGen Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.16 Mil.

OpGen (LTS:0A8L) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

OpGen's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	1.4665	/	0.692	*	365 / 4
	=	193.38

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

OpGen's Inventory Turnover for the quarter that ended in Sep. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.692	/	1.4665
	=	0.47

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

OpGen's Inventory to Revenue for the quarter that ended in Sep. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	1.4665	/	0.699
	=	2.10

OpGen Change In Inventory Related Terms

Thank you for viewing the detailed overview of OpGen's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

OpGen (LTS:0A8L) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OpGen Inc (LTS:0A8L) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

OPGN:USA 650:Germany

Address

9717 Key West Avenue, Suite 100, Rockville, MD, USA, 20850

Website

https://www.opgen.com

OpGen Inc is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It is developing molecular information products and services for healthcare settings, helping to guide clinicians with rapid and actionable information about life-threatening infections, improve patient outcomes, and decrease the spread of infections caused by MDROs. Its proprietary DNA tests and informatics address the rising threat of antibiotic resistance by helping physicians and other healthcare providers optimize care decisions for patients with acute infections. The company's product candidates and services combine its Acuitas molecular diagnostics and Acuitas Lighthouse informatics platform for use with its curated MDRO knowledge base.

OpGen (LTS:0A8L) Headlines

No Headlines